Emrosi™ (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea ...

A study found that DFD-29 was more effective than both doxycycline and placebo, with a favorable risk-benefit profile for ...

It is the only systemic (body-wide) treatment the FDA approved ... Doxycycline is effective for the type known as ...

Approval of the tetracycline antibiotic for this indication was supported by data from two multicenter phase III trials -- ...

A low-dose (40 mg) modified formulation of minocycline hydrochloride (DFD-29) was better tolerated and more effective than doxycycline and placebo in patients with moderate to severe ...